Previous studies have revealed that LOXL1 dysregulation was correlated with advanced-stage cancer and worse prognosis, suggesting a link between LOXL1 expression and tumor progression in various cancers (Ye et al. 2020). Here, LOXL1 is linked to neoplasm.